Big Move For BridgeBio Pharma, Inc.
Mon, Jul 17, 2023 at 07:32 PM
BridgeBio Pharma, Inc. (BBIO:NASDAQ) soared at $32.04, representing a gain of 75.9%. On Mon, Jul 17, 2023, BBIO:NASDAQ touched a New 2-Week High of $32.04. The stock appeared on our News Catalysts scanner on Mon, Jul 17, 2023 at 01:37 PM in the 'MISCELLANEOUS' category. From Mon, Jul 03, 2023, the stock recorded 66.67% Up Days and 50.00% Green Days
About BridgeBio Pharma, Inc. (BBIO:NASDAQ)
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.
Top 10 Gainers:
- ProMIS Neurosciences Inc. (PMN:NASDAQ), 120.28%
- BridgeBio Pharma, Inc. (BBIO:NASDAQ), 75.85%
- Acumen Pharmaceuticals Inc. (ABOS:NASDAQ), 54.78%
- Prestige Wealth Inc. (PWM:NASDAQ), 45.67%
- GreenPower Motor Company Inc. (GP:NASDAQ), 44.25%
- Quantum-Si Incorporated (QSI:NASDAQ), 33.88%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 31.67%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 31.35%
- Kelso Technologies Inc. (KIQ:NYSEMKT), 28.86%
- argenx SE (ARGX:NASDAQ), 27.79%